Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-08

Clinical Trial Update: Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ejaculation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of dapoxetine, silodosin, and citalopram for premature ejaculation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)
  • Dapoxetine (dapoxetine)
  • Silodosin (Silodosin)

Snippet

Sponsor: Beni-Suef University | Conditions: Premature (Early) Ejaculation | Phase 4 | Status: COMPLETED